
### [MONDO:0019271](http://purl.obolibrary.org/obo/MONDO_0019271)
**Label:** acrokeratoderma

**Subclasses:** [MONDO:0007048](http://purl.obolibrary.org/obo/MONDO_0007048) (acrokeratosis verruciformis), [MONDO:0007047](http://purl.obolibrary.org/obo/MONDO_0007047) (punctate palmoplantar keratoderma type III), [MONDO:0010754](http://purl.obolibrary.org/obo/MONDO_0010754) (van den Bosch syndrome), [MONDO:0007417](http://purl.obolibrary.org/obo/MONDO_0007417) (Darier's disease), 

**Mapped go classes:** [GO:0008016](http://purl.obolibrary.org/obo/GO_0008016) (regulation of heart contraction), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0005388](http://purl.obolibrary.org/obo/GO_0005388) (calcium-transporting ATPase activity), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0006811](http://purl.obolibrary.org/obo/GO_0006811) (ion transport), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0006816](http://purl.obolibrary.org/obo/GO_0006816) (calcium ion transport), [GO:0070588](http://purl.obolibrary.org/obo/GO_0070588) (calcium ion transmembrane transport), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0014704](http://purl.obolibrary.org/obo/GO_0014704) (intercalated disc), [GO:0001947](http://purl.obolibrary.org/obo/GO_0001947) (heart looping), [GO:0033017](http://purl.obolibrary.org/obo/GO_0033017) (sarcoplasmic reticulum membrane), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- [GO:0044291](http://purl.obolibrary.org/obo/GO_0044291) (cell-cell contact zone) 66.67%
- [GO:0014704](http://purl.obolibrary.org/obo/GO_0014704) (intercalated disc) 66.67%
- [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding) 66.67%
- [GO:0001947](http://purl.obolibrary.org/obo/GO_0001947) (heart looping) 66.67%
- [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 66.67%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 66.67%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 66.67%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding) 66.67%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0032555](http://purl.obolibrary.org/obo/GO_0032555) (purine ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 66.67%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0032553](http://purl.obolibrary.org/obo/GO_0032553) (ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 66.67%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding) 66.67%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0036094](http://purl.obolibrary.org/obo/GO_0036094) (small molecule binding) 66.67%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 66.67%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0032555](http://purl.obolibrary.org/obo/GO_0032555) (purine ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 66.67%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0032553](http://purl.obolibrary.org/obo/GO_0032553) (ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 66.67%


